Literature DB >> 27181181

Therapeutic inertia or individualization? Delay in clinical management of type 2 diabetes mellitus.

Nagaaki Tanaka1,2, Takeshi Kurose1,2, Yutaka Seino1,2.   

Abstract

Entities:  

Mesh:

Year:  2016        PMID: 27181181     DOI: 10.1080/03007995.2016.1190701

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


× No keyword cloud information.
  4 in total

1.  Safety and Efficacy of Insulin Degludec/Liraglutide (IDegLira) and Insulin Glargine U100/Lixisenatide (iGlarLixi), Two Novel Co-Formulations of a Basal Insulin and a Glucagon-Like Peptide-1 Receptor Agonist, in Patients With Diabetes Not Adequately Controlled on Oral Antidiabetic Medications.

Authors:  Carol H Wysham; Carlos Campos; Davida Kruger
Journal:  Clin Diabetes       Date:  2018-04

2.  Effectiveness of shared goal setting and decision making to achieve treatment targets in type 2 diabetes patients: A cluster-randomized trial (OPTIMAL).

Authors:  Henk Den Ouden; Rimke C Vos; Guy E H M Rutten
Journal:  Health Expect       Date:  2017-05-24       Impact factor: 3.377

3.  Coverage rate of ADME genes from commercial sequencing arrays.

Authors:  Nabil Zaid; Youness Limami; Nezha Senhaji; Nadia Errafiy; Loubna Khalki; Youssef Bakri; Younes Zaid; Saaid Amzazi
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

4.  Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: Results from a Japanese cohort study (JDDM53).

Authors:  Hiroshi Maegawa; Yasushi Ishigaki; Jakob Langer; Ai Saotome-Nakamura; Marc Andersen
Journal:  J Diabetes Investig       Date:  2020-09-01       Impact factor: 4.232

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.